Non-Clinical Cardiovascular Safety Testing: Moving Forward

First Page		Document Content
Clinical research Pharmaceutical industry Pharmaceuticals policy Therapeutics Prescription Drug User Fee Act Drug development Center for Drug Evaluation and Research Grepafloxacin Food and Drug Administration Pharmaceutical sciences Pharmacology		Non-Clinical Cardiovascular Safety Testing: Moving Forward Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 255,11 KB Share Document on Facebook

	Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT DocID: 1t0K4 - View Document
	Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1 Basic PDUFA Construct DocID: 1sUEh - View Document
	Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016 Page 1 1 FOOD AND DRUG ADMINISTRATION (FDA) DocID: 1sUz3 - View Document
	United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight DocID: 1rfHg - View Document
	Best Practices in Developing Proprietary Names for Drugs DocID: 1r8R5 - View Document